Content related to FDA approves new drug for Duchenne MD

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

While other toddlers her age were fighting naptime, two-year-old Michelle was battling an aggressive, life-threatening cancer. Doctors at Children’s Hospital Los Angeles saved her life in an epic

Philanthropist Kirith Prady has established an endowed chair to honor her father, Bram Bernstein, MD, and his legacy in the field of pediatric rheumatology and at Children’s Hospital Los Angeles.

Everybody who knows 6-year-old Andrew Escamilla always expected he would play professional baseball someday. His father, a diehard Dodgers fan, took the boy to see the Men in Blue at Dodger Stadium

Children’s Hospital Los Angeles is evaluating several novel devices for congenital heart disease—and recently performed the world’s first implant of a novel stent for babies.

The most difficult area we still contend with are children who we think are at risk for sudden cardiac arrest. Do they need an implantable defibrillator?

Children’s Hospital Los Angeles is participating in five clinical trials for rare metabolic bone conditions.

Children’s Hospital Los Angeles imaging researchers developed biomarkers for a study seeking treatments for infants with oxygen deprivation damage

Research at Children’s Hospital Los Angeles enables a novel compound to achieve a key designation from the Food and Drug Administration.